Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aristidis Veves, D.Sc., M.D.

Co-Author

This page shows the publications co-authored by Aristidis Veves and Edward Horton.
Connection Strength

0.947
  1. Troglitazone-induced changes in adiponectin do not affect endothelial function in diabetes. Obes Res. 2005 Jul; 13(7):1167-74.
    View in: PubMed
    Score: 0.078
  2. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes. 2005 Jan; 54(1):204-11.
    View in: PubMed
    Score: 0.075
  3. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004 Oct; 27(10):2450-7.
    View in: PubMed
    Score: 0.074
  4. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004 Feb; 89(2):740-7.
    View in: PubMed
    Score: 0.071
  5. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism. 2004 Feb; 53(2):222-7.
    View in: PubMed
    Score: 0.071
  6. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003 Jul; 26(7):2119-25.
    View in: PubMed
    Score: 0.068
  7. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism. 2003 Feb; 52(2):173-80.
    View in: PubMed
    Score: 0.066
  8. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002 Nov 19; 106(21):2680-6.
    View in: PubMed
    Score: 0.065
  9. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc Res. 2002 Jan; 63(1):91-5.
    View in: PubMed
    Score: 0.061
  10. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001 Feb; 24(2):344-9.
    View in: PubMed
    Score: 0.057
  11. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999 Nov; 22(11):1865-70.
    View in: PubMed
    Score: 0.053
  12. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab. 1999 Nov; 84(11):4159-64.
    View in: PubMed
    Score: 0.053
  13. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999 Sep; 48(9):1856-62.
    View in: PubMed
    Score: 0.052
  14. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes. 1997 Nov; 46(11):1846-52.
    View in: PubMed
    Score: 0.046
  15. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med. 2007 Jun; 64(6):373-9.
    View in: PubMed
    Score: 0.022
  16. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005 Jun 07; 111(22):2913-20.
    View in: PubMed
    Score: 0.019
  17. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation. 2003 Jun 03; 107(21):2664-9.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.